Cervarix related Press Releases
Cancer Vaccines Poised to Reach $3 Billion in Sales by 2015
FALLS CHURCH, Va., April 19, 2011 /PRNewswire/ -- Technology Catalysts International (TCI), leading global consultants to the pharmaceutical industry, announced that research on cancer trends and Read more...
New data for GlaxoSmithKline's vaccine, Cervarix, presented at IPV Conference
New data for GlaxoSmithKline's vaccine, Cervarix, presented at IPV Conference Issued: Friday 8 May 2009, London, UK & Malmö, Sweden Key results from three important studies of the cervical
Read more...GlaxoSmithKline submits final study data to FDA for cervical cancer vaccine
Cervarix® U.S. regulatory update GlaxoSmithKline submits final study data to FDA for cervical cancer vaccine Issued: Monday 30th March 2009, Philadelphia US & London UK GlaxoSmithKline
Read more...PRESS RELEASE: GSK submits Cervarix licence application to Japan’s health authorities
GSK submits Cervarix™ licence application to Japan’s health authorities For UK business and financial media (not for distribution to US media) Issued – 28 September 2007, London (UK) and Read more...
PRESS RELEASE: GSK seeks prequalification for Cervarix from the World Health Organization
GSK seeks prequalification for Cervarix™ from the World Health Organization after obtaining marketing approval in Europe For business and financial press only Issued — Thursday 4 October 2007, Read more...
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
